Biocon's arm Syngene gets SEBI nod for IPO
Syngene International, research arm of biotechnology major Biocon, has received capital markets regulator SEBI's approval to launch an initial public offer (IPO).
Jun 15, 2015, 20:15 PM IST
Biocon arm to have 40-acre new plant in Mangalore SEZ
Biocon's research services arm Syngene International would set up a new plant at Mangalore SEZ to manufacture pharma ingredients and agro chemicals.
Mar 31, 2015, 20:33 PM IST
Biocon to file for Syngene unit's IPO in two months: Sources
Biotechnology firm Biocon Ltd could file a prospectus for a share listing for its research services business arm Syngene International within the next two months, two sources directly involved in the process said.
Mar 31, 2015, 17:54 PM IST
